New developments from big brand names such as Swisse, Yili, and Bayer's Elevit were the most-read stories in April. Other popular stories included an exclusive interview with FSSAI's former director on the country's newly operationalised nutraceutical regulations, companies' omnichannel retail strategies and new COVID-19 findings.
Swisse's parent company Health and Happiness Group (H&H Group) has identified five key areas in developing its upcoming next generation products.
A Thai researcher has invented a personalised probiotics dispenser machine that supplies consumers with probiotics strains that they lack in their gut, using bioinformatics and artificial intelligence (AI).
Hong Kong firm GenieBiome has launched its research-backed probiotics that have been shown to speed up recovery in COVID-19 patients in Singapore.
Malaysian Tiger milk mushroom supplier Nexus Wise is eyeing overseas growth amid local success for the ingredient traditionally used for cold, flu, and immunity.
Bayer's maternal nutrition supplement brand, Elevit, has made its debut in the infant nutrition space with new products launched in China last month. Speaking to NutraIngredients-Asia, Bayer Consumer Health China has also outlined the new product pipeline that it has planned for its infant nutrition portfolio, including the launch of DHA and probiotics next year.
China dairy giant Yili has outlined its new product launch strategies, including the introduction of a solid beverage formulated with probiotics and GABA as the key ingredients.
Higher levels of Omega-3 intake, including DHA and EPA, coupled with less junk food consumption, could be two key nutritional factors in explaining Japan's fewer COVID-19 casualties compared to the US.
Online purchase of dietary supplements flourished amid the ongoing COVID-19 pandemic, but how can brands find synergies and success in the ‘best-of-worlds' digital and brick-and-mortar retail approach? We speak to a raft of experts to find out…
A set of new nutraceutical regulations operationalised by the Food Safety and Standards Authority of India (FSSAI) this month will make it easier for companies to innovate and import a broader range of supplements, although there are still some ‘bottlenecks' to overcome, according to a former director at the statutory board.
A group of experts in Asia has finalised 14 consensus statements around muscle health in healthy elderly and those suffering from sarcopenia, including recommendation for protein, leucine, and L-carnitine supplementation.
